CCL21 and breast cancer: Analysis of a cohort of 234 breast cancer patient samples showed a correlation of tumors with aggressive invasive properties and a signature of genes expressed by ILC3, enriched for CXCL13, CCL19, CCL21, and the receptors CXCR5 and CCR7 [84].